This report studies the global Advanced Parenteral drug delivery market status and forecast, categorizes the global Advanced Parenteral drug delivery market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Parenteral drug delivery systems are those devices that inject the medicine doses other than oral route. Parenteral administration route is coined as the most common and efficient for drug delivery of active drug substances with poor bio-availability and drugs with a narrow therapeutic index. For parenteral drug delivery to be an efficient and effective treatment it is often appropriate to uphold systemic drug levels within the therapeutically effective concentration range in cases of long treatment. Overall, the technique seeks to optimize therapeutic index by enabling immediate drug due to the systemic pool in desired quantities.
North American market is expected to have the largest market share due to increasing acceptance of technologically advanced healthcare systems and rising patient awareness levels. European market expected to follow North American market. Asia pacific regional market is expected to be the most lucrative due to increasing penetration, greater untapped opportunity and rapidly improving healthcare infrastructure in emerging economies of China and India.
The global Advanced Parenteral drug delivery market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.
The major players covered in this report
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Government Hospitals
Private Hospitals and Clinics
Healthcare Organizations
Others
The study objectives of this report are:
To analyze and study the global Advanced Parenteral drug delivery sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Advanced Parenteral drug delivery players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Advanced Parenteral drug delivery are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Advanced Parenteral drug delivery Manufacturers
Advanced Parenteral drug delivery Distributors/Traders/Wholesalers
Advanced Parenteral drug delivery Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Advanced Parenteral drug delivery market, by end-use.
Detailed analysis and profiles of additional market players.
Parenteral drug delivery systems are those devices that inject the medicine doses other than oral route. Parenteral administration route is coined as the most common and efficient for drug delivery of active drug substances with poor bio-availability and drugs with a narrow therapeutic index. For parenteral drug delivery to be an efficient and effective treatment it is often appropriate to uphold systemic drug levels within the therapeutically effective concentration range in cases of long treatment. Overall, the technique seeks to optimize therapeutic index by enabling immediate drug due to the systemic pool in desired quantities.
North American market is expected to have the largest market share due to increasing acceptance of technologically advanced healthcare systems and rising patient awareness levels. European market expected to follow North American market. Asia pacific regional market is expected to be the most lucrative due to increasing penetration, greater untapped opportunity and rapidly improving healthcare infrastructure in emerging economies of China and India.
The global Advanced Parenteral drug delivery market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.
The major players covered in this report
Abbott Laboratories
Amgen
Pfizer
Hoffmann-La Roche
AstraZeneca
Baxter
Dickinson
Boston Scientific
Bristol-Myers Squibb
GlaxoSmithKline
Novartis
Becton
AptarGroup
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Prefillable Syringes
Injectors Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Government Hospitals
Private Hospitals and Clinics
Healthcare Organizations
Others
The study objectives of this report are:
To analyze and study the global Advanced Parenteral drug delivery sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Advanced Parenteral drug delivery players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Advanced Parenteral drug delivery are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Advanced Parenteral drug delivery Manufacturers
Advanced Parenteral drug delivery Distributors/Traders/Wholesalers
Advanced Parenteral drug delivery Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Advanced Parenteral drug delivery market, by end-use.
Detailed analysis and profiles of additional market players.
Table of Contents
Global Advanced Parenteral drug delivery Sales Market Report 2018
1 Advanced Parenteral drug delivery Market Overview
1.1 Product Overview and Scope of Advanced Parenteral drug delivery
1.2 Classification of Advanced Parenteral drug delivery by Product Category
1.2.1 Global Advanced Parenteral drug delivery Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Advanced Parenteral drug delivery Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Prefillable Syringes
1.2.4 Injectors Cartridges
1.2.5 Hypodermic Syringes
1.2.6 IV Catheters
1.2.7 Other Parenteral Delivery Devices
1.3 Global Advanced Parenteral drug delivery Market by Application/End Users
1.3.1 Global Advanced Parenteral drug delivery Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Government Hospitals
1.3.2 Private Hospitals and Clinics
1.3.3 Healthcare Organizations
1.3.4 Others
1.4 Global Advanced Parenteral drug delivery Market by Region
1.4.1 Global Advanced Parenteral drug delivery Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.3 Europe Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.4 China Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.5 Japan Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.6 Southeast Asia Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.7 India Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Advanced Parenteral drug delivery (2013-2025)
1.5.1 Global Advanced Parenteral drug delivery Sales and Growth Rate (2013-2025)
1.5.2 Global Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2025)
2 Global Advanced Parenteral drug delivery Competition by Players/Suppliers, Type and Application
2.1 Global Advanced Parenteral drug delivery Market Competition by Players/Suppliers
2.1.1 Global Advanced Parenteral drug delivery Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Advanced Parenteral drug delivery Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Advanced Parenteral drug delivery (Volume and Value) by Type
2.2.1 Global Advanced Parenteral drug delivery Sales and Market Share by Type (2013-2018)
2.2.2 Global Advanced Parenteral drug delivery Revenue and Market Share by Type (2013-2018)
2.3 Global Advanced Parenteral drug delivery (Volume and Value) by Region
2.3.1 Global Advanced Parenteral drug delivery Sales and Market Share by Region (2013-2018)
2.3.2 Global Advanced Parenteral drug delivery Revenue and Market Share by Region (2013-2018)
2.4 Global Advanced Parenteral drug delivery (Volume) by Application
3 United States Advanced Parenteral drug delivery (Volume, Value and Sales Price)
3.1 United States Advanced Parenteral drug delivery Sales and Value (2013-2018)
3.1.1 United States Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
3.1.2 United States Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
3.1.3 United States Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
3.2 United States Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
3.3 United States Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
3.4 United States Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
4 Europe Advanced Parenteral drug delivery (Volume, Value and Sales Price)
4.1 Europe Advanced Parenteral drug delivery Sales and Value (2013-2018)
4.1.1 Europe Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
4.1.2 Europe Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
4.1.3 Europe Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
4.2 Europe Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
5 China Advanced Parenteral drug delivery (Volume, Value and Sales Price)
5.1 China Advanced Parenteral drug delivery Sales and Value (2013-2018)
5.1.1 China Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
5.1.2 China Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
5.1.3 China Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
5.2 China Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
5.3 China Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
5.4 China Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
6 Japan Advanced Parenteral drug delivery (Volume, Value and Sales Price)
6.1 Japan Advanced Parenteral drug delivery Sales and Value (2013-2018)
6.1.1 Japan Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
6.1.2 Japan Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
6.1.3 Japan Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
6.2 Japan Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
7 Southeast Asia Advanced Parenteral drug delivery (Volume, Value and Sales Price)
7.1 Southeast Asia Advanced Parenteral drug delivery Sales and Value (2013-2018)
7.1.1 Southeast Asia Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
7.2 Southeast Asia Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
8 India Advanced Parenteral drug delivery (Volume, Value and Sales Price)
8.1 India Advanced Parenteral drug delivery Sales and Value (2013-2018)
8.1.1 India Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
8.1.2 India Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
8.1.3 India Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
8.2 India Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
8.3 India Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
8.4 India Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
9 Global Advanced Parenteral drug delivery Players/Suppliers Profiles and Sales Data
9.1 Abbott Laboratories
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Abbott Laboratories Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Amgen
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Amgen Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Pfizer
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Pfizer Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Hoffmann-La Roche
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Hoffmann-La Roche Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 AstraZeneca
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 AstraZeneca Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Baxter
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Baxter Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Dickinson
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Dickinson Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Boston Scientific
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Boston Scientific Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Bristol-Myers Squibb
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Bristol-Myers Squibb Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 GlaxoSmithKline
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 GlaxoSmithKline Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Novartis
9.12 Becton
9.13 AptarGroup
10 Advanced Parenteral drug delivery Maufacturing Cost Analysis
10.1 Advanced Parenteral drug delivery Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Advanced Parenteral drug delivery
10.3 Manufacturing Process Analysis of Advanced Parenteral drug delivery
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Advanced Parenteral drug delivery Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Advanced Parenteral drug delivery Major Manufacturers in 2017
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Advanced Parenteral drug delivery Market Forecast (2018-2025)
14.1 Global Advanced Parenteral drug delivery Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Advanced Parenteral drug delivery Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Advanced Parenteral drug delivery Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Advanced Parenteral drug delivery Price and Trend Forecast (2018-2025)
14.2 Global Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Advanced Parenteral drug delivery Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Advanced Parenteral drug delivery Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Advanced Parenteral drug delivery Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Advanced Parenteral drug delivery Sales Forecast by Type (2018-2025)
14.3.2 Global Advanced Parenteral drug delivery Revenue Forecast by Type (2018-2025)
14.3.3 Global Advanced Parenteral drug delivery Price Forecast by Type (2018-2025)
14.4 Global Advanced Parenteral drug delivery Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
Global Advanced Parenteral drug delivery Sales Market Report 2018
1 Advanced Parenteral drug delivery Market Overview
1.1 Product Overview and Scope of Advanced Parenteral drug delivery
1.2 Classification of Advanced Parenteral drug delivery by Product Category
1.2.1 Global Advanced Parenteral drug delivery Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Advanced Parenteral drug delivery Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Prefillable Syringes
1.2.4 Injectors Cartridges
1.2.5 Hypodermic Syringes
1.2.6 IV Catheters
1.2.7 Other Parenteral Delivery Devices
1.3 Global Advanced Parenteral drug delivery Market by Application/End Users
1.3.1 Global Advanced Parenteral drug delivery Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Government Hospitals
1.3.2 Private Hospitals and Clinics
1.3.3 Healthcare Organizations
1.3.4 Others
1.4 Global Advanced Parenteral drug delivery Market by Region
1.4.1 Global Advanced Parenteral drug delivery Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.3 Europe Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.4 China Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.5 Japan Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.6 Southeast Asia Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.4.7 India Advanced Parenteral drug delivery Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Advanced Parenteral drug delivery (2013-2025)
1.5.1 Global Advanced Parenteral drug delivery Sales and Growth Rate (2013-2025)
1.5.2 Global Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2025)
2 Global Advanced Parenteral drug delivery Competition by Players/Suppliers, Type and Application
2.1 Global Advanced Parenteral drug delivery Market Competition by Players/Suppliers
2.1.1 Global Advanced Parenteral drug delivery Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Advanced Parenteral drug delivery Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Advanced Parenteral drug delivery (Volume and Value) by Type
2.2.1 Global Advanced Parenteral drug delivery Sales and Market Share by Type (2013-2018)
2.2.2 Global Advanced Parenteral drug delivery Revenue and Market Share by Type (2013-2018)
2.3 Global Advanced Parenteral drug delivery (Volume and Value) by Region
2.3.1 Global Advanced Parenteral drug delivery Sales and Market Share by Region (2013-2018)
2.3.2 Global Advanced Parenteral drug delivery Revenue and Market Share by Region (2013-2018)
2.4 Global Advanced Parenteral drug delivery (Volume) by Application
3 United States Advanced Parenteral drug delivery (Volume, Value and Sales Price)
3.1 United States Advanced Parenteral drug delivery Sales and Value (2013-2018)
3.1.1 United States Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
3.1.2 United States Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
3.1.3 United States Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
3.2 United States Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
3.3 United States Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
3.4 United States Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
4 Europe Advanced Parenteral drug delivery (Volume, Value and Sales Price)
4.1 Europe Advanced Parenteral drug delivery Sales and Value (2013-2018)
4.1.1 Europe Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
4.1.2 Europe Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
4.1.3 Europe Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
4.2 Europe Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
5 China Advanced Parenteral drug delivery (Volume, Value and Sales Price)
5.1 China Advanced Parenteral drug delivery Sales and Value (2013-2018)
5.1.1 China Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
5.1.2 China Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
5.1.3 China Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
5.2 China Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
5.3 China Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
5.4 China Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
6 Japan Advanced Parenteral drug delivery (Volume, Value and Sales Price)
6.1 Japan Advanced Parenteral drug delivery Sales and Value (2013-2018)
6.1.1 Japan Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
6.1.2 Japan Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
6.1.3 Japan Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
6.2 Japan Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
7 Southeast Asia Advanced Parenteral drug delivery (Volume, Value and Sales Price)
7.1 Southeast Asia Advanced Parenteral drug delivery Sales and Value (2013-2018)
7.1.1 Southeast Asia Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
7.2 Southeast Asia Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
8 India Advanced Parenteral drug delivery (Volume, Value and Sales Price)
8.1 India Advanced Parenteral drug delivery Sales and Value (2013-2018)
8.1.1 India Advanced Parenteral drug delivery Sales and Growth Rate (2013-2018)
8.1.2 India Advanced Parenteral drug delivery Revenue and Growth Rate (2013-2018)
8.1.3 India Advanced Parenteral drug delivery Sales Price Trend (2013-2018)
8.2 India Advanced Parenteral drug delivery Sales Volume and Market Share by Players (2013-2018)
8.3 India Advanced Parenteral drug delivery Sales Volume and Market Share by Type (2013-2018)
8.4 India Advanced Parenteral drug delivery Sales Volume and Market Share by Application (2013-2018)
9 Global Advanced Parenteral drug delivery Players/Suppliers Profiles and Sales Data
9.1 Abbott Laboratories
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Abbott Laboratories Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Amgen
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Amgen Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Pfizer
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Pfizer Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Hoffmann-La Roche
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Hoffmann-La Roche Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 AstraZeneca
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 AstraZeneca Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Baxter
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Baxter Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Dickinson
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Dickinson Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Boston Scientific
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Boston Scientific Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 Bristol-Myers Squibb
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Bristol-Myers Squibb Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 GlaxoSmithKline
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Advanced Parenteral drug delivery Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 GlaxoSmithKline Advanced Parenteral drug delivery Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Novartis
9.12 Becton
9.13 AptarGroup
10 Advanced Parenteral drug delivery Maufacturing Cost Analysis
10.1 Advanced Parenteral drug delivery Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Advanced Parenteral drug delivery
10.3 Manufacturing Process Analysis of Advanced Parenteral drug delivery
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Advanced Parenteral drug delivery Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Advanced Parenteral drug delivery Major Manufacturers in 2017
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Advanced Parenteral drug delivery Market Forecast (2018-2025)
14.1 Global Advanced Parenteral drug delivery Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Advanced Parenteral drug delivery Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Advanced Parenteral drug delivery Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Advanced Parenteral drug delivery Price and Trend Forecast (2018-2025)
14.2 Global Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Advanced Parenteral drug delivery Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Advanced Parenteral drug delivery Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Advanced Parenteral drug delivery Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Advanced Parenteral drug delivery Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Advanced Parenteral drug delivery Sales Forecast by Type (2018-2025)
14.3.2 Global Advanced Parenteral drug delivery Revenue Forecast by Type (2018-2025)
14.3.3 Global Advanced Parenteral drug delivery Price Forecast by Type (2018-2025)
14.4 Global Advanced Parenteral drug delivery Sales Volume Forecast by Application (2018-2025)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.